Global Leaders in Mobile ECG Connectivity
- 20 years of medical credibility licensing technologies to hospitals, physicians, remote patient monitoring platforms, research groups and commercial call centers
- Sold into > 20 countries, with the largest customer base located in the US
- Class II medical device clearances and device agnostic for collecting, viewing, recording, analyzing and storing of ECGs for management of patient and consumer health
- ECG solutions for both consumer (OTC) and medical (Rx) markets
- Owns all IP and source code
- Market expert contributor for reports in mâ€health, mobile cardiac monitoring and new advances in consumer health and wellness monitoring
Recent Highlights
Physician Groups Order The Heartcheck(TM) Cardibeat For In-Home Arrhythmia And Atrial Fibrillation Monitoring
- Confirms market traction with orders being placed by physician groups for the newly launched HeartCheck™ CardiBeat Handheld ECG monitor and GEMS™ Mobile Smartphone app for prescribed in-home arrhythmia monitoring.
- Partners in Advanced Cardiac Evaluation, the largest arrhythmia practice in Ontario (Canada) placed a first order of the HeartCheck™ CardiBeat Handheld ECG monitors and is recommending its patients to use the devices for one year of in-home, self-monitoring with an emphasis on detecting a recurrence of Atrial Fibrillation following cardiac ablation treatment for AF.
Industry News
- INDUSTRY BULLETIN: Wearables For Mhealth Apps: The Future Of The Healthcare Industry
- INDUSTRY BULLETIN: Mhealth – The Magic Convergence of AI, Big Data, Mobile Tech, and Healthcare
- INDUSTRY BULLETIN: Apple, J&J Launch New mHealth Study Targeting Wearables and AFib
- INDUSTRY BULLETIN: M-Health Device Market is Booming Worldwide
Company Accolades
FULL DISCLOSURE: CardioComm Solutions Inc. is an advertising client of AGORA Internet Relations Corp.
Tags: CardiBeat, EKG, mhealth, small cap stocks, stocks, tsx, tsx-v